The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Fatty Acid Synthase As a Potential Therapeutic Target in Cancer
Open accessAbstract
Fatty acid synthase (FASN) is a key enzyme involved in neoplastic lipogenesis. Overexpression of FASN is common in many cancers, and accumulating evidence suggests that it is a metabolic oncogene with an important role in tumor growth and survival, making it an attractive target for cancer therapy. Early small-molecule FASN inhibitors such as cerulenin, C75 and orlistat have been shown to induce apoptosis in several cancer cell lines and to induce tumor growth delay in several cancer xenograft models but their mechanism is still not well understood. These molecules suffer from pharmacological limitations and weight loss as a side effect that prevent their development as systemic drugs. Several potent inhibitors have recently been reported that may help to unravel and exploit the full potential of FASN as a target for cancer therapy in the near future. Furthermore, novel sources of FASN inhibitors, such as green tea and dietary soy, make both dietary manipulation and chemoprevention potential alternative modes of therapy in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Menendez, J. A., & Lupu, R. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2222 · Cited by 2,941
Reduced Food Intake and Body Weight in Mice Treated with Fatty Acid Synthase Inhibitors
Loftus, T. M., Jaworsky, D. E., Frehywot, G. L., Townsend, C. A., Ronnett, G. V., Lane, M. D., & Kuhajda, F. P. (2000) · Science · doi:10.1126/science.288.5475.2379 · Cited by 1,004
Targeting Multiple Signaling Pathways by Green Tea Polyphenol (−)-Epigallocatechin-3-Gallate
Khan, N., Afaq, F., Saleem, M., Ahmad, N., & Mukhtar, H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3636 · Cited by 820
Platensimycin is a selective FabF inhibitor with potent antibiotic properties
Wang, J., Soisson, S. M., Young, K., Shoop, W., Kodali, S., Galgoci, A., Painter, R., Parthasarathy, G., Tang, Y. S., Cummings, R., et al. (2006) · Nature · doi:10.1038/nature04784 · Cited by 812
Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology
Kuhajda, F. P. (2000) · Nutrition · doi:10.1016/s0899-9007(99)00266-x · Cited by 788
Fatty Acid Synthase and Cancer: New Application of an Old Pathway
Kuhajda, F. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4673 · Cited by 647
Structural and functional organization of the animal fatty acid synthase
Smith, S., Witkowski, A., & Joshi, A. K. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(02)00067-x · Cited by 643
Increased lipogenesis in cancer cells: new players, novel targets
Swinnen, J. V., Brusselmans, K., & Verhoeven, G. (2006) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000232894.28674.30 · Cited by 610
Orlistat Is a Novel Inhibitor of Fatty Acid Synthase with Antitumor Activity
Kridel, S. J., Axelrod, F., Rozenkrantz, N., & Smith, J. W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3645 · Cited by 607
Synthesis and antitumor activity of an inhibitor of fatty acid synthase
Kuhajda, F. P., Pizer, E. S., Li, J. N., Mani, N. S., Frehywot, G. L., & Townsend, C. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3450 · Cited by 567
De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy
Mashima, T., Seimiya, H., & Tsuruo, T. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605007 · Cited by 555
The Crystal Structure of a Mammalian Fatty Acid Synthase
Maier, T., Leibundgut, M., & Ban, N. (2008) · Science · doi:10.1126/science.1161269 · Cited by 505
Brusselmans, K., Vrolix, R., Verhoeven, G., & Swinnen, J. V. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m408177200 · Cited by 474
Architecture of Mammalian Fatty Acid Synthase at 4.5 Å Resolution
Maier, T., Jenni, S., & Ban, N. (2006) · Science · doi:10.1126/science.1123248 · Cited by 400
Furuta, E., Pai, S. K., Zhan, R., Bandyopadhyay, S., Watabe, M., Mo, Y.-Y., Hirota, S., Hosobe, S., Tsukada, T., Miura, K., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2489 · Cited by 392
Fatty Acid Synthase: A Metabolic Enzyme and Candidate Oncogene in Prostate Cancer
Migita, T., Ruiz, S., Fornari, A., Fiorentino, M., Priolo, C., Zadra, G., Inazuka, F., Grisanzio, C., Palescandolo, E., Shin, E., et al. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp030 · Cited by 387
Self-citationThe isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer
Graner, E., Tang, D., Rossi, S., Baron, A., Migita, T., Weinstein, L. J., Lechpammer, M., Huesken, D., Zimmermann, J., Signoretti, S., et al. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00055-8 · Cited by 367
Self-citationPizer, E. S., Thupari, J. N., Han, W. F., Pinn, M. L., Chrest, F. J., Frehywot, G. L., Townsend, C. A., & Kuhajda, F. P. (2000) · PubMed · Cited by 366
Enzymes of the fatty acid synthesis pathway are highly expressed in in situ breast carcinoma.
Milgraum, L. Z., Witters, L. A., Pasternack, G. R., & Kuhajda, F. P. (1997) · PubMed · Cited by 333
Menendez, J. A., Vellon, L., Mehmi, I., Oza, B. P., Ropero, S., Colomer, R., & Lupu, R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403390101 · Cited by 327
Fatty acid synthase expression defines distinct molecular signatures in prostate cancer.
Rossi, S., Graner, E., Febbo, P. G., Weinstein, L. J., Bhattacharya, N., Ónody, T., Bubley, G. J., Balk, S. P., & Loda, M. F. (2003) · PubMed · Cited by 301
Self-citationInhibition of fatty acid synthesis induces programmed cell death in human breast cancer cells.
Pizer, E. S., Jackisch, C., Wood, F. D., Pasternack, G. R., Davidson, N. E., & Kuhajda, F. P. (1996) · PubMed · Cited by 291
Pizer, E. S., Wood, F. D., Heine, H. S., Romantsev, F. E., Pasternack, G. R., & Kuhajda, F. P. (1996) · PubMed · Cited by 277
Schrijver, E. D., Brusselmans, K., Heyns, W., Verhoeven, G., & Swinnen, J. V. (2003) · PubMed · Cited by 269
C75 increases peripheral energy utilization and fatty acid oxidation in diet-induced obesity
Thupari, J. N., Landree, L. E., Ronnett, G. V., & Kuhajda, F. P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132128899 · Cited by 262
Swinnen, J. V., Van Veldhoven, P. P., Timmermans, L., De Schrijver, E., Brusselmans, K., Vanderhoydonc, F., Van de Sande, T., Heemers, H., Heyns, W., & Verhoeven, G. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00265-1 · Cited by 259
Pizer, E. S., Chrest, F. J., DiGiuseppe, J. A., & Han, W. F. (1998) · PubMed · Cited by 250
Yoon, S., Lee, M.-Y., Park, S. W., Moon, J.-S., Koh, Y.-K., Ahn, Y.-H., Park, B.-W., & Kim, K.-S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702854200 · Cited by 224
Liu, H., Liu, Y., & Zhang, J.-T. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0445 · Cited by 216
Structure and function of animal fatty acid synthase
Chirala, S. S., & Wakil, S. J. (2004) · Lipids · doi:10.1007/s11745-004-1329-9 · Cited by 215
Shurbaji, M. S., Kalbfleisch, J. H., & Thurmond, T. S. (1996) · Human Pathology · doi:10.1016/s0046-8177(96)90218-x · Cited by 208
Brain fatty acid synthase activates PPARα to maintain energy homeostasis
Chakravarthy, M. V., Zhu, Y., López, M., Yin, L., Wozniak, D. F., Coleman, T., Hu, Z., Wolfgang, M., Vidal-Puig, A., Lane, M. D., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31183 · Cited by 207
Brusselmans, K., De Schrijver, E., Heyns, W., Verhoeven, G., & Swinnen, J. V. (2003) · International Journal of Cancer · doi:10.1002/ijc.11317 · Cited by 205
Vazquez‐Martin, A., Colomer, R., Brunet, J., Lupu, R., & Menendez, J. A. (2008) · Cell Proliferation · doi:10.1111/j.1365-2184.2007.00498.x · Cited by 199
Wang, H. Q., Altomare, D. A., Skele, K. L., Poulikakos, P. I., Kuhajda, F. P., Di Cristofano, A., & Testa, J. R. (2005) · Oncogene · doi:10.1038/sj.onc.1208463 · Cited by 198
Thupari, J. N., Pinn, M. L., & Kuhajda, F. P. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5146 · Cited by 190
Crystal structure of the thioesterase domain of human fatty acid synthase inhibited by Orlistat
Pemble, C. W., Johnson, L. C., Kridel, S. J., & Lowther, W. T. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1265 · Cited by 186
Green Tea Epigallocatechin Gallate: A Natural Inhibitor of Fatty-Acid Synthase
Wang, X., & Tian, W. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5923 · Cited by 182
Inhibition of Fatty Acid Synthase Induces Endoplasmic Reticulum Stress in Tumor Cells
Little, J. L., Wheeler, F. B., Fels, D. R., Koumenis, C., & Kridel, S. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1794 · Cited by 181
Binding Site of Cerulenin in Fatty Acid Synthetase1
Funabashi, H., Kawaguchi, A., Tomoda, H., Ömura, S., Okuda, S., & Iwasaki, S. (1989) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a122739 · Cited by 179
Menendez, J. A., Vellon, L., & Lupu, R. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi239 · Cited by 179
Cohort Study of Fatty Acid Synthase Expression and Patient Survival in Colon Cancer
Ogino, S., Nosho, K., Meyerhardt, J. A., Kirkner, G. J., Chan, A. T., Kawasaki, T., Giovannucci, E. L., Loda, M., & Fuchs, C. S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.2675 · Cited by 178
Self-citationCarvalho, M. A., Zecchin, K. G., Seguin, F., Bastos, D. C., Agostini, M., Rangel, A. L. C. A., Veiga, S. S., Raposo, H. F., Oliveira, H. C. F., Loda, M., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23835 · Cited by 171
Self-citationStructure and molecular organization of mammalian fatty acid synthase
Asturias, F. J., Chadick, J. Z., Cheung, I. K., Stark, H., Witkowski, A., Joshi, A. K., & Smith, S. (2005) · Nature Structural & Molecular Biology · doi:10.1038/nsmb899 · Cited by 170
Fatty acid synthase inhibitors are chemopreventive for mammary cancer in neu-N transgenic mice
Alli, P. M., Pinn, M. L., Jaffee, E. M., McFadden, J. M., & Kuhajda, F. P. (2005) · Oncogene · doi:10.1038/sj.onc.1208174 · Cited by 167
Li, J. N., Gorospe, M., Chrest, F. J., Kumaravel, T. S., Evans, M. K., Han, W. F., & Pizer, E. S. (2001) · PubMed · Cited by 166
Mechanism of Apoptosis Induced by the Inhibition of Fatty Acid Synthase in Breast Cancer Cells
Bandyopadhyay, S., Zhan, R., Wang, Y., Pai, S. K., Hirota, S., Hosobe, S., Takano, Y., Saito, K., Furuta, E., Iiizumi, M., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3197 · Cited by 165
Zhou, W., Han, W. F., Landree, L. E., Thupari, J. N., Pinn, M. L., Bililign, T., Kim, E. K., Vadlamudi, A., Medghalchi, S. M., Meskini, R. E., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3439 · Cited by 161
Fatty acid synthase expression in melanoma
Innocenzi, D., Alò, P. L., Balzani, A., Sebastiani, V., Silipo, V., La Torre, G., Ricciardi, G., Bosman, C., & Calvieri, S. (2003) · Journal of Cutaneous Pathology · doi:10.1034/j.1600-0560.2003.300104.x · Cited by 159
Piyathilake, C. J., Frost, A. R., Manne, U., Bell, W. C., Weiss, H. L., Heimburger, D. C., & Grizzle, W. E. (2000) · Human Pathology · doi:10.1053/hupa.2000.9842 · Cited by 157
Hoover, H. S., Blankman, J. L., Niessen, S., & Cravatt, B. F. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.06.091 · Cited by 150
A fatty acid synthase blockade induces tumor cell-cycle arrest by down-regulating Skp2
Knowles, L. M., Axelrod, F., Browne, C. D., & Smith, J. W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405061200 · Cited by 146
Fiorentino, M., Zadra, G., Palescandolo, E., Fedele, G., Bailey, D., Fiore, C., Nguyen, P. L., Migita, T., Zamponi, R., Vizio, D. D., et al. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.97 · Cited by 139
Self-citationde Sande, T. V., Roskams, T., Lerut, E., Joniau, S., Poppel, H. V., Verhoeven, G., & Swinnen, J. V. (2005) · The Journal of Pathology · doi:10.1002/path.1760 · Cited by 136
Kusakabe, T., Nashimoto, A., Honma, K., & Suzuki, T. (2002) · Histopathology · doi:10.1046/j.1365-2559.2002.01289.x · Cited by 136
Fatty acid synthase (FAS) is a marker of increased risk of recurrence in lung carcinoma.
Visca, P., Sebastiani, V., Botti, C., Diodoro, M. G., Lasagni, R. P., Romagnoli, F., Brenna, A., de Joannon, B. C., Donnorso, R. P., Lombardi, G., et al. (2004) · PubMed · Cited by 128
Fatty acid synthase gene overexpression and copy number gain in prostate adenocarcinoma☆
SHAH, U., Dhir, R., Gollin, S. M., Chandran, U. R., Lewis, D. A., Acquafondata, M. B., & Pflug, B. R. (2006) · Human Pathology · doi:10.1016/j.humpath.2005.11.022 · Cited by 126
Selective Inhibition of Fatty Acid Synthase for Lung Cancer Treatment
Orita, H., Coulter, J. B., Lemmon, C., Tully, E., Vadlamudi, A., Medghalchi, S. M., Kuhajda, F. P., & Gabrielson, E. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1186 · Cited by 125
Bandyopadhyay, S., Pai, S. K., Watabe, M., Gross, S. C., Hirota, S., Hosobe, S., Tsukada, T., Miura, K., Saito, K., Markwell, S. J., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208555 · Cited by 123
Puig, T., Vázquez‐Martín, A., Relat, J., Pétriz, J., Menéndez, J. A., Porta, R., Casals, G., Marrero, P. F., Haro, D., Brunet, J., et al. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9678-5 · Cited by 117
Inhibition of Fatty Acid Synthase by Polyphenols
Tian, W. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706776361012 · Cited by 116
Expression of fatty acid synthase as a prognostic indicator in soft tissue sarcomas.
Tajino, T., Kikuchi, S., & Toshimitsu, S. (2003) · PubMed · Cited by 116
Menendez, J., & Lupu, R. (2006) · Current Pharmaceutical Biotechnology · doi:10.2174/138920106779116900 · Cited by 113
Browne, C. D., Hindmarsh, E. J., & Smith, J. W. (2006) · The FASEB Journal · doi:10.1096/fj.05-5404com · Cited by 108
Knowles, L. M., Chen, Y., Osterman, A. L., & Smith, J. W. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803384200 · Cited by 100
Novel Inhibitors of Fatty Acid Synthase with Anticancer Activity
Puig, T., Turrado, C., Benhamú, B., Aguilar, H., Relat, J., Ortega‐Gutiérrez, S., Casals, G., Marrero, P. F., Urruticoechea, A., Haro, D., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0856 · Cited by 95
Menéndez, J. A., & Lupu, R. (2006) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000232893.21050.15 · Cited by 93
Metabolic Profiles of Minimally Absorbed Orlistat in Obese/Overweight Volunteers
Zhi, J., Melia, A. T., Funk, C., Viger, A., Gérard Hopfgartner, D., Lausecker, B., Wang, K., Fulton, J. S., Gabriel, L., & Mulligan, T. E. (1996) · The Journal of Clinical Pharmacology · doi:10.1177/009127009603601104 · Cited by 92
Inhibiting Fatty Acid Synthase for Chemoprevention of Chemically Induced Lung Tumors
Orita, H., Coulter, J. B., Tully, E., Kuhajda, F. P., & Gabrielson, E. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4177 · Cited by 92
Interaction between fatty acid synthase- and ErbB-systems in ovarian cancer cells.
Grunt, T., Wagner, R., Grusch, M., Berger, W., Singer, C., Marian, B., Zielinski, C., & Lupu, R. (2009) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2009.05.085 · Cited by 91
Brink, J., Ludtke, S. J., Kong, Y., Wakil, S. J., Ma, J., & Chiu, W. (2004) · Structure · doi:10.1016/j.str.2004.01.015 · Cited by 90
McFadden, J. M., Medghalchi, S. M., Thupari, J. N., Pinn, M. L., Vadlamudi, A., Miller, K. I., Kuhajda, F. P., & Townsend, C. A. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049389h · Cited by 89
Choi, W.-I., Jeon, B.-N., Park, H., Yoo, J.-Y., Kim, Y., Koh, D., Kim, M.-H., Kim, Y.-R., Lee, C.-E., Kim, K.-S., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802477200 · Cited by 88
Vázquez‐Martín, A., Colomer, R., Brunet, J., & Menéndez, J. A. (2007) · International Journal of Oncology · doi:10.3892/ijo.31.4.769 · Cited by 85
Menéndez, J. A., Decker, J. P., & Lupu, R. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20310 · Cited by 84
Fatty Acid Synthase and AKT Pathway Signaling in a Subset of Papillary Thyroid Cancers
Shahab Uddin, M. S., Siraj, A. K., Al-Rasheed, M. M., Ahmed, M., Bu, R., Myers, J. N., Al-Nuaim, A. A., Al-Sobhi, S. S., Al‐Dayel, F., Bavi, P. P., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0503 · Cited by 82
Purohit, V. C., Richardson, R. D., Smith, J. W., & Romo, D. (2006) · The Journal of Organic Chemistry · doi:10.1021/jo060392d · Cited by 80
Menéndez, J. A., & Lupu, R. (2004) · PubMed · Cited by 77
Ma, G., Zancanella, M. A., Oyola, Y., Richardson, R. D., Smith, J. W., & Romo, D. (2006) · Organic Letters · doi:10.1021/ol061651o · Cited by 75
MARTEL, P., BINGHAM, C., MCGRAW, C., Baker, C., Morganelli, P. M., MENG, M., Armstrong, J. O., Moncur, J. T., & Kinlaw, W. B. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.10.022 · Cited by 73
Menéndez, J. A., Lupu, R., & Colomer, R. (2005) · Drug News & Perspectives · doi:10.1358/dnp.2005.18.6.927929 · Cited by 73
Rendina, A. R., & Cheng, D. (2005) · Biochemical Journal · doi:10.1042/bj20041963 · Cited by 72
Vazquez-Martin, A., Ropero, S., Brunet, J., Colomer, R., & Menéndez, J. A. (2007) · Oncology Reports · doi:10.3892/or.18.4.973 · Cited by 67
Dowling, S. C., Cox, J., & Cenedella, R. J. (2009) · Lipids · doi:10.1007/s11745-009-3298-2 · Cited by 67
Liu, X., Shi, Y., Giranda, V. L., & Luo, Y. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0049 · Cited by 63
Key role of mitochondria in cerulenin-mediated apoptosis
Heiligtag, S., Bredehorst, R., & David, K. A. (2002) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401055 · Cited by 59
3-Aryl-4-hydroxyquinolin-2(1H)-one derivatives as type I fatty acid synthase inhibitors
Rivkin, A., Kim, Y. R., Goulet, M. T., Bays, N. W., Hill, A. D., Kariv, I., Krauss, S., Ginanni, N., Strack, P. R., Kohl, N. E., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.06.014 · Cited by 55
Gastrointestinal stromal tumours overexpress fatty acid synthase
Rossi, S., Ou, W., Tang, D., Bhattacharya, N., Tos, A. P. D., Fletcher, J. A., & Loda, M. F. (2006) · The Journal of Pathology · doi:10.1002/path.1983 · Cited by 54
Self-citationIncreased fatty acid synthase as a potential therapeutic target in multiple myeloma
Wang, W., Zhao, X., Wang, H., & Liang, Y. (2008) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b0740640 · Cited by 54
Puig, T., Relat, J., Marrero, P. F., Haro, D., Brunet, J., & Colomer, R. (2008) · PubMed · Cited by 49
The Fatty Acid Synthase Gene is a Conserved p53 Family Target Gene from Worm to Human
D’Erchia, A. M., Tullo, A., Lefkimmiatis, K., Saccone, C., & Sbisà, E. (2006) · Cell Cycle · doi:10.4161/cc.5.7.2622 · Cited by 48
Vázquez, M. J., Leavens, W. J., Liu, R., Rodríguez, B., Read, M., Richards, S., Winegar, D. A., & Domı́nguez, J. M. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06314.x · Cited by 47
Malonyl-CoA decarboxylase inhibition is selectively cytotoxic to human breast cancer cells
Zhou, W., Tu, Y., Simpson, P. J., & Kuhajda, F. P. (2009) · Oncogene · doi:10.1038/onc.2009.160 · Cited by 47
Synthesis of Novel β-Lactone Inhibitors of Fatty Acid Synthase
Richardson, R. D., Ma, G., Oyola, Y., Zancanella, M., Knowles, L., Cieplak, P., Romo, D., & Smith, J. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800321h · Cited by 46
Kearney, K. E., Pretlow, T. G., & Pretlow, T. P. (2009) · International Journal of Cancer · doi:10.1002/ijc.24356 · Cited by 37
Xiao, R., Su, Y., Simmen, R. C. M., & Simmen, F. A. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00515.2007 · Cited by 31
Murakami, S., Noguchi, T., Takeda, K., & Ichijo, H. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00551.x · Cited by 30
Wang, X., Lin, J., Chen, Y., Zhong, W., Zhao, G., Liu, H., Li, S., Wang, L., & Li, S. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.01.050 · Cited by 30
β-Lactam congeners of orlistat as inhibitors of fatty acid synthase
Zhang, W., Richardson, R. D., Chamni, S., Smith, J. W., & Romo, D. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.02.043 · Cited by 23
Little, J. L., Wheeler, F. B., Koumenis, C., & Kridel, S. J. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0558 · Cited by 20
Fatty Acid Synthase Expression in Paget??s Disease of the Vulva
Alò, P., Galati, G. M., Sebastiani, V., Ricci, F., Visca, P., Mariani, L., Romagnoli, F., Lombardi, G., & Tondo, U. D. (2005) · International Journal of Gynecological Pathology · doi:10.1097/01.pgp.0000170065.53813.81 · Cited by 13
Does FASing Out New Fat in the Hypothalamus Make You Slim?
Buettner, C. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.09.008 · Cited by 3
Cited by
The emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926
Cancer metabolism: a therapeutic perspective
Martinez-Outschoorn, U. E., Peiris-Pagés, M., Pestell, R. G., Sotgia, F., & Lisanti, M. P. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.60 · Cited by 1,505
Targeting cancer metabolism: a therapeutic window opens
Vander Heiden, M. G. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3504 · Cited by 1,411
Lipid metabolic reprogramming in cancer cells
Beloribi-Djefaflia, S., Vasseur, S., & Guillaumond, F. (2016) · Oncogenesis · doi:10.1038/oncsis.2015.49 · Cited by 1,398
Targeting cellular metabolism to improve cancer therapeutics
Zhao, Y., Butler, E. B., & Tan, M. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.60 · Cited by 989
Metadata
- Authors
- Flavin, R., Peluso, S., Nguyen, P. L., & Loda, M.
- Venue
- Future Oncology
- Publisher
- Informa UK Limited
- Published
- 2010-04-07
- Volume
- 6
- Issue
- 4
- Pages
- 551-562
- ISSN
- 1479-6694 (ISSN-L)
- 1744-8301
- OpenAlex
- W1986234170
- Cited by
- 545
- References
- 102
- FWCI
- 5.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.